It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Prediabetes affects one in three people and has a 10% annual conversion rate to type 2 diabetes without lifestyle or medical interventions. Management of glycemic health is essential to prevent progression to type 2 diabetes. However, there is currently no commercially-available and noninvasive method for monitoring glycemic health to aid in self-management of prediabetes. There is a critical need for innovative, practical strategies to improve monitoring and management of glycemic health. In this study, using a dataset of 25,000 simultaneous interstitial glucose and noninvasive wearable smartwatch measurements, we demonstrated the feasibility of using noninvasive and widely accessible methods, including smartwatches and food logs recorded over 10 days, to continuously detect personalized glucose deviations and to predict the exact interstitial glucose value in real time with up to 84% and 87% accuracy, respectively. We also establish methods for designing variables using data-driven and domain-driven methods from noninvasive wearables toward interstitial glucose prediction.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details


1 Duke University, Department of Biomedical Engineering, Durham, USA (GRID:grid.26009.3d) (ISNI:0000 0004 1936 7961)
2 Duke University, Department of Statistical Science, Durham, USA (GRID:grid.26009.3d) (ISNI:0000 0004 1936 7961)
3 Division of Endocrinology, Department of Medicine, Duke University Medical Center, Durham, USA (GRID:grid.189509.c) (ISNI:0000000100241216)
4 Duke University, Department of Biomedical Engineering, Durham, USA (GRID:grid.26009.3d) (ISNI:0000 0004 1936 7961); Department of Biostatistics and Bioinformatics, Duke University Medical Center, Durham, USA (GRID:grid.414179.e) (ISNI:0000 0001 2232 0951)